for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BRIEF-Aldeyra Therapeutics Announces New Drug Application Development Plans For Dry Eye Disease

July 7 (Reuters) - Aldeyra Therapeutics Inc:

* ALDEYRA THERAPEUTICS ANNOUNCES NEW DRUG APPLICATION (NDA) DEVELOPMENT PLANS FOR DRY EYE DISEASE

* ALDEYRA THERAPEUTICS INC - TOP-LINE RESULTS FROM FIRST OF TWO PLANNED CLINICAL TRIALS BASED ON TEAR RASP LEVELS EXPECTED BY END OF 2020

* ALDEYRA THERAPEUTICS INC - NEW DRUG APPLICATION SUBMISSION FOR REPROXALAP IN DRY EYE DISEASE EXPECTED BY END OF 2021

* ALDEYRA THERAPEUTICS INC - BASED ON CURRENT OPERATING PLANS, CURRENT CASH EXPECTED TO SUPPORT OPERATIONS INTO 2022 Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up